|
1
|
Qureshi AI, Mendelow AD and Hanley DF:
Intracerebral haemorrhage. Lancet. 373:1632–1644. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
D'souza N, Rossignoli F, Golinelli G,
Grisendi G, Spano C, Candini O, Osturu S, Catani F, Paolucci P,
Horwitz EM, et al: Mesenchymal stem/stromal cells as a delivery
platform in cell and gene therapies. BMC Med. 13:1862015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shinozuka K, Dailey T, Tajiri N, Ishikawa
H, Kaneko Y and Borlongan CV: Stem cell transplantation for
neuroprotection in stroke. Brain Sci. 3:239–261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Borlongan CV, Glover LE, Tajiri N, Kaneko
Y and Freeman TB: The great migration of bone marrow-derived stem
cells toward the ischemic brain: Therapeutic implications for
stroke and other neurological disorders. Prog Neurobiol.
95:213–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu X, Ye R, Yan T, Yu SP, Wei L, Xu G,
Fan X, Jiang Y, Stetler RA, Liu G, et al: Cell based therapies for
ischemic stroke: From basic science to bedside. Prog Neurobiol.
115:92–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dailey T, Metcalf C, Mosley YI, Sullivan
R, Shinozuka K, Tajiri N, Pabon M, Acosta S, Kaneko Y, van Loveren
H, et al: An update on translating stem cell therapy for stroke
from bench to bedside. J Clin Med. 2:220–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zou Z, Zhang Y, Hao L, Wang F, Liu D, Su Y
and Sun H: More insight into mesenchymal stem cells and their
effects inside the body. Expert Opin Biol Ther. 10:215–230. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qu Z, Guo L, Fang G, Cui Z, Guo S and Liu
Y: Biological characteristics and effect of human umbilical cord
mesenchymal stem cells (hUC-MSCs) grafting with blood plasma on
bone regeneration in rats. Cell Biochem Biophys. 63:171–181. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qu Z, Guo S, Fang G, Cui Z and Liu Y: AKT
pathway affect bone regeneration in nonunion treated with umbilical
cord-derived mesenchymal stem. Cell Biochem Biophys. 71:1543–1551.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu Z, Fang G, Cui Z and Liu Y: Cell
therapy for bone nonunion: A retrospective study. Minerva Med.
106:315–321. 2015.PubMed/NCBI
|
|
12
|
Kim SJ, Moon GJ, Chang WH, Kim YH and Bang
OY: STARTING-2 (STem cell Application Researches and Trials In
NeuroloGy-2) collaborators: Intravenous transplantation of
mesenchymal stem cells preconditioned with early phase stroke
serum: Current evidence and study protocol for a randomized trial.
Trials. 14:3172013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qu ZG, Liu Y, Guo LB and Bi WW:
Percutaneous radiological autologous bone-marrow mesenchymal stem
cells grafting integrating blood plasma by injection in the part of
thigh fracture: Seven-month follow-up effect evaluation in one
case. J Clin Reh Tis Eng Res. 13:7393–7396. 2009.
|
|
14
|
Saino O, Taguchi A, Nakagomi T, Nakano-Doi
A, Kashiwamura S, Doe N, Nakagomi N, Soma T, Yoshikawa H, Stern DM,
et al: Immunodeficiency reduces neural stem/progenitor cell
apoptosis and enhances neurogenesis in the cerebral cortex after
stroke. J Neurosci Res. 88:2385–2397. 2010.PubMed/NCBI
|
|
15
|
Hunt JS, Petroff MG, McIntire RH and Ober
C: HLA-G and immune tolerance in pregnancy. FASEB J. 19:681–693.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Menier C, Rouas-Freiss N, Favier B,
LeMaoult J, Moreau P and Carosella ED: Recent advances on the
non-classical major histocompatibility complex class I HLA-G
molecule. Tissue Antigens. 75:201–206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JM, Jung J, Lee HJ, Jeong SJ, Cho KJ,
Hwang SG and Kim GJ: Comparison of immunomodulatory effects of
placenta mesenchymal stem cells with bone marrow and adipose
mesenchymal stem cells. Int Immunopharmacol. 13:219–224. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fazekasova H, Lechler R, Langford K and
Lombardi G: Placenta-derived MSCs are partially immunogenic and
less immunomodulatory than bone marrow-derived MSCs. J Tissue Eng
Regen Med. 5:684–694. 2011. View
Article : Google Scholar : PubMed/NCBI
|
